High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV

AIDS. 2005 May 20;19(8):785-94. doi: 10.1097/01.aids.0000168972.65304.6b.

Abstract

Objective: To examine associations between levels of episomal and integrated human papillomavirus (HPV) 16 DNA and the grade of cervical disease.

Design: Cross-sectional data were obtained from a cohort of women with and without HIV infection and with high-risk sexual behaviour.

Methods: Episomal and integrated HPV-16 DNA loads were measured in cervicovaginal lavages collected from 75 women (58 HIV seropositive, 17 HIV seronegative) using real-time polymerase chain reaction assays, controlling for cell content and the presence of inhibitors.

Results: HPV-16 viral loads were significantly higher in women with high-grade squamous intraepithelial lesions (n = 6) than in women with normal cytology (n = 44), whether total (10(8.28) versus 10(5.10) HPV-16 DNA copies/microg DNA), episomal (10(7.99) versus 10(4.61)) or integrated (10(7.95) versus 10(4.77)) HPV-16 viral loads were measured (P < 0.02 for each comparison). Thirty-nine women had colposcopy [11 normal cervix, 16 cervical intraepithelial neoplasia (CIN) 1, six CIN 2, six CIN 3] and 24 additional women had three consecutive normal cytology smears. Controlling for age, race, CD4 cell count and HIV status, total (OR 3.5, 95% CI 1.2-10.4; P = 0.02), episomal (OR 2.9, 95% CI 1.2-7.4; P = 0.02,) and integrated (OR 1.6, 95% CI 1-2.6; P = 0.05) HPV-16 DNA loads were significantly associated with CIN 2,3, but the differences between CIN 1 and CIN 2,3 were not significant (P > 0.06). A greater amount of cellular DNA was collected from women with CIN 2,3 (P = 0.007).

Conclusion: Higher HPV-16 DNA loads are associated with cervical lesions detected by either histology or cytology. No additional information is gained by measuring integrated or episomal over total HPV-16 DNA loads.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Cervix Uteri / virology
  • Colposcopy
  • Cross-Sectional Studies
  • DNA Probes, HPV
  • DNA, Viral / analysis*
  • Female
  • HIV Infections / virology*
  • Humans
  • Papillomaviridae / genetics*
  • Papillomavirus Infections / virology*
  • Polymerase Chain Reaction
  • Risk-Taking
  • Tumor Virus Infections / virology
  • Uterine Cervical Dysplasia / virology
  • Uterine Cervical Neoplasms / virology*
  • Vaginal Smears
  • Viral Load

Substances

  • DNA Probes, HPV
  • DNA, Viral